Provectus Biopharmaceuticals,

CUSIP: 74373F100 Class: COM

PRINCETON CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001167026)

Note: Option positions (PUT/CALL) are excluded.

Q4 2013
Shares 25,000 Value ($000) $60 Avg Close — Range —
Q3 2013
Shares 25,000 Value ($000) $19 Avg Close — Range —
Q2 2013
Shares 25,000 Value ($000) $16 Avg Close — Range —